Bayer and Cipla recently settled their trademark dispute over veterinary products, with Cipla agreeing to compensation and ceasing use of contested marks. This case illustrates how IP litigation often leads to settlement, especially in high-impact sectors.
Read more about Trademark Litigation: ‘Advantage’ of SettlementTag: CIPLA
Roche’s backbone rendered brittle by Indian Patent Office
The Indian Patent Office has revoked Roche’s patent on Bonviva after Cipla challenged its validity, citing a lack of inventive step and patentability. This decision highlights critical aspects of Indian pharmaceutical patent law and its impact on international drug companies.
Read more about Roche’s backbone rendered brittle by Indian Patent Office